GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Debt-to-Revenue

International Biotechnology Trust (LSE:IBT) Debt-to-Revenue : 0.48 (As of Feb. 2024)


View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

International Biotechnology Trust's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was £0.00 Mil. International Biotechnology Trust's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was £27.67 Mil. International Biotechnology Trust's annualized Revenue for the quarter that ended in Feb. 2024 was £58.25 Mil. International Biotechnology Trust's annualized Debt-to-Revenue for the quarter that ended in Feb. 2024 was 0.48.


International Biotechnology Trust Debt-to-Revenue Historical Data

The historical data trend for International Biotechnology Trust's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Debt-to-Revenue Chart

International Biotechnology Trust Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A 0.33 0.75 N/A 3.82

International Biotechnology Trust Semi-Annual Data
Aug14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.74 0.68 N/A 0.48

Competitive Comparison of International Biotechnology Trust's Debt-to-Revenue

For the Biotechnology subindustry, International Biotechnology Trust's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Biotechnology Trust's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Debt-to-Revenue falls into.



International Biotechnology Trust Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

International Biotechnology Trust's Debt-to-Revenue for the fiscal year that ended in Aug. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 32.474) / 8.494
=3.82

International Biotechnology Trust's annualized Debt-to-Revenue for the quarter that ended in Feb. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 27.669) / 58.25
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Feb. 2024) Revenue data.


International Biotechnology Trust Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


International Biotechnology Trust (LSE:IBT) Business Description

Traded in Other Exchanges
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines